Logistics and Delivery to Destination

The contract requires the full transport and final delivery of Sodium Nitroprusside vials to a designated destination, with the contractor assuming complete responsibility for all transportation risks, regulatory compliance, and ensuring timely arrival without delay. This includes adherence to all applicable pharmaceutical handling, storage, and transit standards to maintain product integrity throughout the supply chain. The scope encompasses end-to-end logistics from origin to final delivery point, with no allocation of risk or liability to the requesting agency. The solicitation, issued under the NAICS code 484220 for truck transportation of freight, is structured as a subcontract and was posted on May 10, 2026, with a response deadline of May 18, 2026. The contracting entity is the Department of Defense through its Medical Supply Chain Pharm FSA office, though specific performance locations and point of contact details are not provided. Bidders must demonstrate proven capability in handling sensitive pharmaceutical shipments under strict regulatory frameworks, and submissions must be received by the stated deadline to be considered.